Beta
Back to APH.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

APH Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q4'25, SG&A Expenses for APH reached $691M USD, marking the highest point in the observed period, while R&D Expenses remained at no data across all quarters. This latest data point reflects a continued upward trajectory in operational costs driven solely by SG&A, with no contribution from R&D. From Q1'23 to Q4'25, SG&A Expenses exhibited a consistent upward trend, increasing from $346M USD to $691M USD, representing a roughly 100% growth over the 12-quarter span, with notable acceleration in 2024 and 2025 (e.g., quarterly jumps exceeding $50M USD in later periods). R&D Expenses showed no data throughout, indicating a potential focus on sales, general, and administrative functions without reported research investments; the stacked bar chart highlights SG&A as the dominant component of total operating expenses, underscoring rising cost pressures amid business expansion.